Thursday, August 20, 2026. 12 PM-1:30 PM ET
Hear from an expert in HER2 IHC whose work has contributed to current scoring guidelines.
Webinar presenter Josef Ruschoff, MD, PhD, Former Chief Medical Officer and Co-Founder of Targos, Senior Consultant of Discovery Life Sciences, Kassel, Germany.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
To be rescheduled to a future date
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
March 13, 2026—The Food and Drug Administration has cleared the Qiagen QIAstat-Dx Gastrointestinal Panel 2 and QIAstat-Dx GI Panel 2 Mini B and Mini B&V for use on the QIAstat-Dx Rise automated syndromic testing system.
March 12, 2026—The FDA has granted breakthrough device designation to MeMed’s BV Flex, a blood test designed to distinguish between bacterial and viral infections based on the body’s immune response.
March 11, 2026—Biocartis’ Idylla CDx MSI test has received class C companion diagnostic certification under the European Union IVDR.
March 9, 2026—Agilent Technologies has entered into a definitive agreement to acquire Biocare Medical in an all-cash transaction valued at $950 million.
March 4, 2026—A new report from KLAS Research awarded Proscia the highest overall performance score (95.2) in the U.S. market, based on customer feedback.
Feb. 26, 2026—ARUP Laboratories has launched the Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners.
Feb. 25, 2026—Labcorp is expanding its collaboration with PathAI to deploy PathAI’s AISight Dx, an FDA-cleared digital pathology platform, across its anatomic pathology labs and hospital collaborations.
Feb. 24, 2026—Exa Capital has acquired StaffReady, an SaaS platform for managing clinical workforces in health care.
Feb. 23, 2026—Copan Group’s PhenoMatrix, an automated image assessment software used with the company’s WASPLab laboratory automation platform, received FDA 510(k) clearance as a class II device.
Feb. 20, 2026—Arlington Scientific has completed its acquisition of Awareness Technology’s EIA/ELISA product line.
